Top section
Top section
Raiffeisen Holding NÖ-Wien sells Strabag block as Fincantieri falls
Shipbuilder's shares fall 10% after capital raise
Founder of climate investing think tank wants to apply ideas as bond investor
NextEra and TotalEnergies grind €3.25bn tight over seniors
◆ Energy pair bring three tranches ◆ Sub-100bp senior/hybrid spreads secured ◆ Single digit concessions offered
NatWest plays for duration with long-dated holding company senior
◆ Two steps to terms debated ◆ Priced flat to fair value or even with negative concession ◆ Investors split on long-dated holdco supply
Founder of climate investing think tank wants to apply ideas as bond investor
Sub-sections
-
US market remains the model as template issuance takes shape -
◆ AFT's Antoine Deruennes says 'clear message' showed demand for 30 year ◆ Speedy execution before US employment data ◆ Green OAT syndication next
-
◆ Refi deal came as issuer prepares IPO ◆ Deal extends the insurer's tier two curve by 10 years ◆ 'Strong bid' for Iberian FIG credit, says rival banker
-
◆ Portuguese utility firm powers up EuGB curve ◆ Sub-benchmark trade's book proves sticky ◆ Deal lands through fair value
-
◆ €500m 4NC3 EuGB deal priced inside fair value ◆ Greenium helps tighten spreads amid strong demand ◆ Landmark trade cements bank's ESG leadership, says treasurer
-
◆ Austrian lender completes its tightest unsecured debt since the start of war in Ukraine… ◆ …as BPM achieves its lowest ever senior spread ◆ High attrition function of premium and outright spread
-
When loans' LTVs hit 80%, Bitcoin stakes are liquidated in seconds
-
-
Latest issue rides on coattails of big tech investment spree
-
Deal is backed by three data centers in Virginia, Illinois and Atlanta
-
Only one of Canada's big five banks has yet to publicly support new defence bank initiative
-
Hyperscaler earnings could become a crucial date for issuance funding calendars
-
The yield was ultra high but Congo had little room to manoeuvre
-
Benin showed Islamic issuance is a viable market for sub-Saharan African sovereigns
-
Sovereign left little, if anything, on the table for investors
-
Observers have questioned why the country is issuing debt at this price
-
Deal will bring fourth major multilateral development bank to the market
-
The bank's regular appearances in primary markets stopped after Russia invaded Ukraine
-
-
Craig Coben examines whether it is true that no good deed goes unpunished
-
Investors and bankers grapple with 24% fall in Bitcoin since deal was rated
-
Investors have got a fever, and the only cure is more pharma. Biotech equity issuance is surging, in line with rising stock prices in the secondary market, as stock pickers pan for the company that will cure Covid-19, among other maladies. But this is more speculating than investing and many are going to catch a cold chasing around a risky sector that is starting to look a lot like the dot-com bubble.
-
Freeline Theraputics, the UK gene therapeutics company, has filed to list in the US on the Nasdaq exchange, continuing the trend of biotech companies seeking to raise capital in the equity capital markets.
-
The Covid-19 pandemic is forcing many governments to expand their borrowing programmes. The table below details the impact of the outbreak on the funding requirements of major sovereign bond issuers.
-
Sponsored by Islamic Development Bank (IsDB)
Sukuk market’s next chapter: Financing the future, sustainably
-
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
